The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab, an investigational anti-PD-1 antibody, combined with chemotherapy as first-line treatment for lung cancer in Chinese patients.
 
Jie Wang
No Relationships to Disclose
 
Jun Zhao
No Relationships to Disclose
 
Zhijie Wang
No Relationships to Disclose
 
Zhiyong Ma
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose
 
Yongqian Shu
No Relationships to Disclose
 
Zhe Liu
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Shiangjiin Leaw
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Fan Xia
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Yanjie Wu
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Liang Liang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Honoraria - BeiGene